Unlike other brands that release their ads days or weeks ahead of the Big Game, Novartis is waiting to unveil its commercial during the contest.

Novartis has committed $7.5 million to an initiative aiming to save 100,000 lives by 2035. The money will launch Zero ...

Are you a print subscriber? Activate your account. By Tim Nudd - 19 hours 17 min ago By Amir Farhang - 19 hours 17 min ago By Ashley Joseph - 1 day 17 hours ago By Ad Age Staff - 1 day 17 hours ...

Mid-2025 LOE is expected for Tasigna, Promacta, and Entresto in the U.S., with continued strong growth from other key brands and launches anticipated to offset these impacts. Novartis reaffirmed ...

After Novartis and Roche grew their sales last year, the Swiss pharma giants are handing their CEOs larger compensation packages for 2024. | After Novartis and Roche grew their sales last year, the ...

Swiss pharmaceutical giant Novartis announced on Tuesday the purchase of Cambridge-based biopharma firm Anthos Therapeutics for $925 million upfront. The deal, which is expected to close in the ...

Novartis is expanding its prospects in cardiometabolic disease by striking a deal to acquire Anthos Therapeutics, a company in pivotal testing with a blood clot-preventing drug that could offer ...

Hailee Steinfeld and Wanda Sykes team up with pharmaceutical company Novartis to raise breast cancer awareness.

Wide-moat Novartis reported fourth-quarter results ... disease (Leqvio), and rare disease (Fabhalta). These growing brands should be able to more than offset the declining sales of older drugs ...

Novartis NOVN0.30%increase; green up pointing triangle agreed to acquire Blackstone Life Sciences’ Anthos Therapeutics for up to $3.08 billion to boost its cardiovascular-drug pipeline. The deal ...

But Steinfeld is gearing up for another arena. Steinfeld is teaming up with pharmaceutical company Novartis to raise awareness about breast cancer with a bold and empowering commercial that will ...

The same year, Novartis acquired the North American over-the-counter brand portfolio of Bristol-Myers Squibb. In 2006, Novartis announced the creation of a biomedical R&D centre in Shangai ...